We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Overcoming Lentiviral Development Challenges

Overcoming Lentiviral Development Challenges
Credit: iStock

Lentiviruses play a crucial role in biopharma due to their unique drug-delivery potential. However, the development of lentiviral-based therapies can still face challenges including safety concerns, immunogenicity and bioprocessing scale-up issues.


To ensure that products are safe, effective and profitable, it’s essential that vector development is supported by the latest in proteomic and genomic characterization technologies.


This content pack contains a variety of webinars, technical notes and a compendium of resources to help you overcome the common lentiviral development challenges in your lab.


Download this content pack to discover: 

  • Innovative solutions for more comprehensive proteome characterization
  • The latest workflows for gene therapy analysis
  • Powerful methods for host cell contaminant detection 

Brought to you by
Download This Content Pack for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.